Search

everythinglearnresearchcommunity

for

Search:↓

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Injecting CHIR-99021 into goose embryos improves feather growth by changing gene activity and energy processes.

Developing microRNA-based treatments is hard but has potential.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

The research found that the properties of solid-state Electronic Circular Dichroism (ss-ECD) are influenced by the orientation of local crystals, which could help in examining and mapping chiral materials like pharmaceutical ingredients.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Isoproterenol helps hair follicle stem cells turn into beating heart muscle cells.

The DiLiCre mouse model is an effective tool for precise genome editing using light.

Using three-hair grafts from the back of the head for eyebrow transplantation offers a natural look and reduces scarring.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

M30 is a promising treatment for preventing hair loss during chemotherapy.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

miR-133b promotes hair growth and could be a potential treatment for hair loss.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

miR-486 may help prevent hair loss in alopecia areata.

The nanohybrid system significantly improved wound healing and showed strong antibacterial activity.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

A group has developed therapies that show promise for treating cancer and various other conditions.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

GI197111X is best dissolved in Capmul MCM for trials.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The MIRA technique improves cellulite treatment results and patient satisfaction.